John M. Kelton, Pharm.D.,is US Medical Director, Oncology Biosimilars, Biomarkers for Pfizer, Inc. and has 25 plus years of experience in the pharmaceutical industry. Since 2000, John’s focus has been on Medical Affairs, serving in a variety of capacities, including management of Medical Communications and Training, Medical Review, Medical Education, Medical Science Liaisons, and Investigator Initiated Trials.
For the past seven years, John has been actively involved in biosimilar development and educational efforts in the United States and Europe. John has collaborated with biosimilars experts that have expertise ranging from bench to bedside in Nephrology, Inflammation, and Oncology in order to capture and communicate the unique aspects of biosimilars and their development programs. Recently John has assumed US Medical Affairs responsibility for biomarkers in Colorectal Cancer.
Prior to his roles in Medical Affairs, John functioned as Regional Pharmacy Manager for Abbott where he managed pharmacy operations for parenteral and nutritional products as well as key clinical relationships with major healthcare systems. John received his Doctor of Pharmacy from the University of Southern California. Before joining industry, John practiced as a clinical pharmacist, specializing in parenteral nutrition and oncology.